文献速递结核与非结核分枝杆菌

晚期潜伏结核再激活率的系统综述

Quantifying the rates of late reactivation tuberculosis: a systematic review.
PubMed 文献 · Lancet Infect Dis · 2021-04-20

该系统综述检索八个数据库至2019年6月25日,纳入110项研究,分四组评估感染2年以上发生的晚期结核再激活率。仅11项研究记录了有明确感染时间的未治疗队列,结核发病率随时间下降,第5年约降至每10万人年200例或以下;再感染与年龄影响使解读受限。

要点

  • 有明确感染时间的未治疗队列仅11项,随访均不超过10年。
  • 第5年左右结核发病率约≤200例/10万人年,之后可能继续下降但证据受限。
  • 暴露史不明的潜伏感染队列10年后发病率降至<100例/10万人年。

核心结论

  • 晚期再激活率常被用于建模和制定结核控制策略,但相关认识仍存在显著缺口。
  • 晚期再激活与早期进展对全球结核负担的相对重要性仍不清楚。

研究设计与样本

  • 系统综述,检索八个数据库(起始至2019年6月25日),PROSPERO注册号CRD42017070594。
  • 纳入110项研究,分为四组:暴露后血清转换队列(n=14)、暴露后潜伏感染队列(n=11)、暴露史不明的潜伏感染队列(n=86)、生态学研究(n=7)。

主要发现

  • 仅11项研究记录了有明确感染时间的未治疗队列的晚期再激活率(第1组或第2组)。
  • 这11项研究中6项随访至少4年,无一超过10年。
  • 这些研究显示结核发病率随时间下降,第5年约达每10万人年200例或以下。
  • 暴露史不明的潜伏感染队列(第3组)发病率一般低于第1、2组,筛查后10年以上降至每10万人年100例以下。

关键数值与推荐

  • 晚期再激活定义为感染2年以上发生的结核再激活。
  • 第5年左右结核发病率约≤200例/10万人年,5年后可能进一步下降但受队列缩小或规模不明限制。
  • 暴露史不明队列筛查10年后发病率<100例/10万人年。

临床怎么用

  • 为结核消除策略的优先级排序提供晚期再激活率估算依据。
  • 应用现有再激活率建模时需注意其多来自随访有限、存在再感染混杂的队列。

局限性

  • 所有研究均受再感染风险影响,限制了解读。
  • 年龄对晚期再激活的作用不明确。
  • 有明确感染时间的未治疗队列研究少且随访均不超过10年。
  • 晚期再激活与早期进展对全球结核负担的相对贡献未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The risk of tuberculosis is greatest soon after infection, but Mycobacterium tuberculosis can remain in the body latently, and individuals can develop disease in the future, sometimes years later. However, there is uncertainty about how often reactivation of latent tuberculosis infection (LTBI) occurs. We searched eight databases (inception to June 25, 2019) to identify studies that quantified tuberculosis reactivation rates occurring more than 2 years after infection (late reactivation), with a focus on identifying untreated study cohorts with defined timing of LTBI acquisition (PROSPERO registered: CRD42017070594). We included 110 studies, divided into four methodological groups. Group 1 included studies that documented late reactivation rates from conversion (n=14) and group 2 documented late reactivation rates in LTBI cohorts from exposure (n=11). Group 3 included 86 studies in LTBI cohorts with an unknown exposure history, and group 4 included seven ecological studies. Since antibiotics have been used to treat tuberculosis, only 11 studies have documented late reactivation rates in infected, untreated cohorts from either conversion (group 1) or exposure (group 2); six of these studies lasted at least 4 years and none lasted longer than 10 years. These studies found that tuberculosis rates declined over time, reaching approximately 200 cases per 100 000 person-years or less by the fifth year, and possibly declining further after 5 years but interpretation was limited by decreasing or unspecified cohort sizes. In cohorts with latent tuberculosis and an unknown exposure history (group 3), tuberculosis rates were generally lower than those seen in groups 1 and 2, and beyond 10 years after screening, rates had declined to less than 100 per 100 000 person-years. Reinfection risks limit interpretation in all studies and the effect of age is unclear. Late reactivation rates are commonly estimated or modelled to prioritise tuberculosis control strategies towards tubuculosis elimination, but significant gaps remain in our understanding that must be acknowledged; the relative importance of late reactivation versus early progression to the global burden of tuberculosis remains unknown.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dale KD, Karmakar M, Snow KJ, et al. Quantifying the rates of late reactivation tuberculosis: a systematic review. Lancet Infect Dis. 2021. PMID: 33891908. doi:10.1016/S1473-3099(20)30728-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。